US 8865755
Dual-acting antihypertensive agents
granted A61KA61K31/4196A61K45/06
Quick answer
US patent 8865755 (Dual-acting antihypertensive agents) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4196, A61K45/06, A61P, A61P13/12